肾部分切除术与根治性肾切除术以及年龄对转移性肾细胞癌其他原因死亡率的影响:倾向评分匹配研究

IF 2.3 4区 医学 Q3 ONCOLOGY Surgical Oncology-Oxford Pub Date : 2024-02-13 DOI:10.1016/j.suronc.2024.102047
Carolin Siech , Reha-Baris Incesu , Simone Morra , Lukas Scheipner , Andrea Baudo , Letizia Maria Ippolita Jannello , Mario de Angelis , Jordan A. Goyal , Zhe Tian , Fred Saad , Shahrokh F. Shariat , Derya Tilki , Nicola Longo , Luca Carmignani , Ottavio de Cobelli , Sascha Ahyai , Alberto Briganti , Philipp Mandel , Luis A. Kluth , Felix K.H. Chun , Pierre I. Karakiewicz
{"title":"肾部分切除术与根治性肾切除术以及年龄对转移性肾细胞癌其他原因死亡率的影响:倾向评分匹配研究","authors":"Carolin Siech ,&nbsp;Reha-Baris Incesu ,&nbsp;Simone Morra ,&nbsp;Lukas Scheipner ,&nbsp;Andrea Baudo ,&nbsp;Letizia Maria Ippolita Jannello ,&nbsp;Mario de Angelis ,&nbsp;Jordan A. Goyal ,&nbsp;Zhe Tian ,&nbsp;Fred Saad ,&nbsp;Shahrokh F. Shariat ,&nbsp;Derya Tilki ,&nbsp;Nicola Longo ,&nbsp;Luca Carmignani ,&nbsp;Ottavio de Cobelli ,&nbsp;Sascha Ahyai ,&nbsp;Alberto Briganti ,&nbsp;Philipp Mandel ,&nbsp;Luis A. Kluth ,&nbsp;Felix K.H. Chun ,&nbsp;Pierre I. Karakiewicz","doi":"10.1016/j.suronc.2024.102047","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>It is unknown whether the benefit from partial nephrectomy regarding lower other-cause mortality is applicable to older patients with metastatic renal cell carcinoma.</p></div><div><h3>Materials and methods</h3><p>Using Surveillance Epidemiology and End Results database, patients with metastatic renal cell carcinoma, undergoing partial or radical nephrectomy, were stratified according to age (&lt;60, 60–69, and ≥70 years). After propensity score matching, Kaplan-Meier survival analyses and multivariable Cox regression models were used.</p></div><div><h3>Results</h3><p>Of 2,390 patients with metastatic renal cell carcinoma, 885 (37%) were aged &lt;60 years, and 90 (10%) underwent partial nephrectomy; 824 (34%) were aged 60–69 years, and 61 (7%) underwent partial nephrectomy; and 681 (29%) were aged ≥70 years, and 64 (9%) underwent partial nephrectomy. After propensity score matching, in patients aged &lt;60 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.22; p = 0.02); in patients aged 60–69 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.38; p = 0.03); but not in patients aged ≥70 years.</p></div><div><h3>Discussion</h3><p>In metastatic renal cell carcinoma, partial nephrectomy is associated with lower other-cause mortality in patients aged &lt;60 years and in patients aged 60–69 years, but not in patients aged ≥70 years. In consequence, consideration of partial nephrectomy might be of great value in younger metastatic renal cell carcinoma patients.</p></div>","PeriodicalId":51185,"journal":{"name":"Surgical Oncology-Oxford","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S096074042400015X/pdfft?md5=5b14dad3f6316ce0b2ef86b2584b4e7b&pid=1-s2.0-S096074042400015X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study\",\"authors\":\"Carolin Siech ,&nbsp;Reha-Baris Incesu ,&nbsp;Simone Morra ,&nbsp;Lukas Scheipner ,&nbsp;Andrea Baudo ,&nbsp;Letizia Maria Ippolita Jannello ,&nbsp;Mario de Angelis ,&nbsp;Jordan A. Goyal ,&nbsp;Zhe Tian ,&nbsp;Fred Saad ,&nbsp;Shahrokh F. Shariat ,&nbsp;Derya Tilki ,&nbsp;Nicola Longo ,&nbsp;Luca Carmignani ,&nbsp;Ottavio de Cobelli ,&nbsp;Sascha Ahyai ,&nbsp;Alberto Briganti ,&nbsp;Philipp Mandel ,&nbsp;Luis A. Kluth ,&nbsp;Felix K.H. Chun ,&nbsp;Pierre I. Karakiewicz\",\"doi\":\"10.1016/j.suronc.2024.102047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>It is unknown whether the benefit from partial nephrectomy regarding lower other-cause mortality is applicable to older patients with metastatic renal cell carcinoma.</p></div><div><h3>Materials and methods</h3><p>Using Surveillance Epidemiology and End Results database, patients with metastatic renal cell carcinoma, undergoing partial or radical nephrectomy, were stratified according to age (&lt;60, 60–69, and ≥70 years). After propensity score matching, Kaplan-Meier survival analyses and multivariable Cox regression models were used.</p></div><div><h3>Results</h3><p>Of 2,390 patients with metastatic renal cell carcinoma, 885 (37%) were aged &lt;60 years, and 90 (10%) underwent partial nephrectomy; 824 (34%) were aged 60–69 years, and 61 (7%) underwent partial nephrectomy; and 681 (29%) were aged ≥70 years, and 64 (9%) underwent partial nephrectomy. After propensity score matching, in patients aged &lt;60 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.22; p = 0.02); in patients aged 60–69 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.38; p = 0.03); but not in patients aged ≥70 years.</p></div><div><h3>Discussion</h3><p>In metastatic renal cell carcinoma, partial nephrectomy is associated with lower other-cause mortality in patients aged &lt;60 years and in patients aged 60–69 years, but not in patients aged ≥70 years. In consequence, consideration of partial nephrectomy might be of great value in younger metastatic renal cell carcinoma patients.</p></div>\",\"PeriodicalId\":51185,\"journal\":{\"name\":\"Surgical Oncology-Oxford\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-02-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S096074042400015X/pdfft?md5=5b14dad3f6316ce0b2ef86b2584b4e7b&pid=1-s2.0-S096074042400015X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical Oncology-Oxford\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S096074042400015X\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Oncology-Oxford","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S096074042400015X","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

材料和方法利用监测流行病学和最终结果数据库,对接受肾部分切除术或根治性肾切除术的转移性肾细胞癌患者按年龄进行分层(60岁、60-69岁和≥70岁)。经过倾向评分匹配后,采用卡普兰-梅耶生存分析和多变量考克斯回归模型。结果 在2390名转移性肾细胞癌患者中,885人(37%)年龄为60岁,90人(10%)接受了肾部分切除术;824人(34%)年龄为60-69岁,61人(7%)接受了肾部分切除术;681人(29%)年龄≥70岁,64人(9%)接受了肾部分切除术。经过倾向评分匹配后,在<60岁的患者中,肾部分切除术与较低的其他原因死亡率相关(危险比为0.22;P = 0.02);在60-69岁的患者中,肾部分切除术与较低的其他原因死亡率相关(危险比为0.讨论在转移性肾细胞癌患者中,肾部分切除术与降低60岁和60-69岁患者的其他原因死亡率有关,但与降低≥70岁患者的其他原因死亡率无关。因此,考虑对年轻的转移性肾细胞癌患者进行肾部分切除术可能具有重要价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study

Introduction

It is unknown whether the benefit from partial nephrectomy regarding lower other-cause mortality is applicable to older patients with metastatic renal cell carcinoma.

Materials and methods

Using Surveillance Epidemiology and End Results database, patients with metastatic renal cell carcinoma, undergoing partial or radical nephrectomy, were stratified according to age (<60, 60–69, and ≥70 years). After propensity score matching, Kaplan-Meier survival analyses and multivariable Cox regression models were used.

Results

Of 2,390 patients with metastatic renal cell carcinoma, 885 (37%) were aged <60 years, and 90 (10%) underwent partial nephrectomy; 824 (34%) were aged 60–69 years, and 61 (7%) underwent partial nephrectomy; and 681 (29%) were aged ≥70 years, and 64 (9%) underwent partial nephrectomy. After propensity score matching, in patients aged <60 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.22; p = 0.02); in patients aged 60–69 years, partial nephrectomy was associated with lower other-cause mortality (hazard ratio 0.38; p = 0.03); but not in patients aged ≥70 years.

Discussion

In metastatic renal cell carcinoma, partial nephrectomy is associated with lower other-cause mortality in patients aged <60 years and in patients aged 60–69 years, but not in patients aged ≥70 years. In consequence, consideration of partial nephrectomy might be of great value in younger metastatic renal cell carcinoma patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Surgical Oncology-Oxford
Surgical Oncology-Oxford 医学-外科
CiteScore
4.50
自引率
0.00%
发文量
169
审稿时长
38 days
期刊介绍: Surgical Oncology is a peer reviewed journal publishing review articles that contribute to the advancement of knowledge in surgical oncology and related fields of interest. Articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation. Surgical Oncology publishes comprehensive Reviews that examine individual topics in considerable detail, in addition to editorials and commentaries which focus on selected papers. The journal also publishes special issues which explore topics of interest to surgical oncologists in great detail - outlining recent advancements and providing readers with the most up to date information.
期刊最新文献
Machine learning in cancer prognostication: Limitations and opportunities. Bilobed lateral artery perforator-based flap for partial breast reconstruction - Technique description and results from a ten-year cohort. Individualizing care for patients with gallbladder cancer Natural history of salivary gland secretory carcinoma: A REFCOR study. Tumor necrosis drives prognosis in osteosarcoma: No difference in chemotherapy response and survival between chondroblastic and osteoblastic osteosarcoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1